Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis.
By E. Mills, J. Nachega, Iain E. Buchan, J. Orbinski, A. Attaran, Sonal Singh, B. Rachlis, Ping Wu, C. Cooper, Lehana Thabane and 3 more. Journal of the American Medical Association (JAMA), 2006
963 citations recorded by the source corpus.
Subfields: Family Practice, General Health Professions, Infectious Diseases
View Paper: https://www.semanticscholar.org/paper/02f1b3e4570b5a4253c29751dc8c33e3a792999e
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In General Health Professions
Citations in the corpus
- The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. (2011, methodology): “Adherence to Antiretroviral Therapy A meta-analysis of 31 North American adherence studies found that 55% of HIV-infected individuals achieve adequate adherence [56].”
- Quantifying an Adherence Path-Specific Effect of Antiretroviral Therapy in the Nigeria PEPFAR Program (2014, background): “, 2001) and are considered similarly important in the treatment of HIV (Mills et al., 2006; Vranceanu et al., 2008; Pop-Eleches et al., 2011).”
- Patient Retention in Antiretroviral Therapy Programs in Sub-Saharan Africa: A Systematic Review (2007, background): “The bibliographies of five recently published reviews of treatment outcomes, mortality, or ARV adherence in resource-constrained settings were also searched [1–3,5,6].”
- Adherence to HAART: A Systematic Review of Developed and Developing Nation Patient-Reported Barriers and Facilitators (2006, methodology): “We examined both developed and developing nation patient populations [11].”
- Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders (2011, background): “Significant challenges include the large numbers of individuals on ART who are residentially dispersed and who face structural and economic constraints to sustained treatment access [9].”